SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-23-127362
Filing Date
2023-12-19
Accepted
2023-12-19 16:52:03
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2332968d1_s1.htm S-1 268516
2 EXHIBIT 5.1 tm2332968d1_ex5-1.htm EX-5.1 8045
3 EXHIBIT 23.1 tm2332968d1_ex23-1.htm EX-23.1 3327
4 EX-FILING FEES tm2332968d1_ex-filingfees.htm EX-FILING FEES 22055
5 GRAPHIC tm2332968d1_ex5-1img01.jpg GRAPHIC 5466
6 GRAPHIC tm2332968d1_s1-img01.jpg GRAPHIC 6117
7 GRAPHIC tm2332968d1_s1-img02.jpg GRAPHIC 20777
8 GRAPHIC tm2332968d1_s1-img03.jpg GRAPHIC 5925
  Complete submission text file 0001104659-23-127362.txt   356332
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-276145 | Film No.: 231498121
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)